All Stories

  1. Transcriptome Profile Reveals Differences between Remote and Ischemic Myocardium after Acute Myocardial Infarction in a Swine Model
  2. Intracoronary Administration of Microencapsulated HGF in a Reperfused Myocardial Infarction Swine Model
  3. Intrapericardial Administration of Secretomes from Menstrual Blood-Derived Mesenchymal Stromal Cells: Effects on Immune-Related Genes in a Porcine Model of Myocardial Infarction
  4. A Fibrin Coating Method of Polypropylene Meshes Enables the Adhesion of Menstrual Blood-Derived Mesenchymal Stromal Cells: A New Delivery Strategy for Stem Cell-Based Therapies
  5. IFN-Gamma and TNF-Alpha as a Priming Strategy to Enhance the Immunomodulatory Capacity of Secretomes from Menstrual Blood-Derived Stromal Cells
  6. Interferon-gamma and TNF-alpha synergistically enhance the immunomodulatory capacity of Endometrial-Derived Mesenchymal Stromal Cell secretomes by differential microRNA and extracellular vesicle release
  7. Characterization of proteins and miRNAs in extracellular vesicles from porcine CDCs
  8. Multi-layered coating with fibrin glue for surgical meshes ease stem cell adhesion and viability
  9. IP injection of extracellular vesicles from heart-derived cells is safe after myocardial infarction
  10. Extracellular Vesicles from Cardiosphere-Derived Cells Stimulates M2 Polarization
  11. New stem cell therapy may modulate the unbalanced inflammation in the damaged cardiac tissue.
  12. High-throughput proteomics of extracellular vesicles derived from endometrial Mesenchymal Stem Cells
  13. Method to create a preclinical free skin flap model in rats with ischemia-reperfusion injury.
  14. Conditioned serum (CS, “Orthokine”) has been used intra-articularly for osteoarthritic patients
  15. Intracoronary administration of allogeneic pig cardiac-derived progenitor cells
  16. Peripheral blood lymphocyte alterations may be good biomarkers for predict MI severity
  17. Mesenchymal stem cell-based therapies for soft tissue reinforcement.
  18. Analysis of extracellular vesicles from endometrial-derived mesenchymal stem cells
  19. The ischemia-reperfunion injury reduced the survival of free flaps
  20. The immunomodulatory functions mediated by melatonin support its use as vaccine adjuvant.
  21. Several blood parameters allowed predict the severity of myocardial infarction in a animal model
  22. EV‐endMSCs increase the developmental competence of IVF‐derived embryos from aged females
  23. The endMSCs are multipotent stem cells and exhibit immunomodulatory effects.
  24. The percentage flap survival area was significantly higher in the adipose stem cells treated flaps
  25. EV-endMSCs may be used as a co-adjuvant to improve in vitro fertilization and embryo quality
  26. Therapeutic effect of MSCs and exosomes combined with FG for the treatment of incisional hernia
  27. Safety and effectiveness of an intracoronary infusion of microencapsulated IGF-1 and HGF.
  28. Immunological evaluation of a clinically relevant model of synovitis
  29. Mesenchymal Stem Cell-Derived Exosomes: Immunomodulatory Evaluation in an Antigen-Induced Synovitis
  30. Analysis of bone-marrow derived MSCs and leukocyte from Large White pigs and Göttingen Minipigs
  31. Limitations of natural killer cell-based cancer immunotherapy.
  32. The improvement in glucose metabolism seems to occur by means of the redistribution of body fat.
  33. Filters for the isolation exosomes could be an alternative to protocols using ultracentrifugation.
  34. Viability, metabolic activity and immunomodulation assays on MSCs-coated meshes
  35. Mesenchymal stem cell derived exosomes in the treatment of synovitis.
  36. Intrapericardial administration of cardiosphere-derived cells may have an immunomodulatory effect
  37. The combined usage of surgical meshes with MSCs, provides an anti-inflammatory environment
  38. Combination of mesenchymal stem cells and biomimetic matrices for cell-based therapies
  39. Acute myeloid leukaemia (AML) is generally a disease of older adults
  40. Administration of cardiac stem cell for acute myocardial infarction could ameliorate remodeling.
  41. Development of canine adipose stem cell lines for the allogeneic treatment of osteoarticular disease
  42. Bio-distribution analysis of intrapericardal administration of mesenchymal stem cells
  43. Hemostatic collagen sponge, application and control for gynecological use.
  44. The use of cardiac-derived cell products reported highly promising results with autologous cells.
  45. Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes
  46. Safety and efficacy assessment of intracoronary delivery of porcine cardiac stem cells
  47. Allogenic cardiac stem cells administration for the treatment of acute Myocardial Infarction
  48. The intrapericardial delivery, an efficient method for pharmacological agent delivery
  49. Development of new sutures to improve wound healing
  50. Cytokine profiles in acute myeloid leukemia patients at diagnosis
  51. MSCs produce specific interactions with immune cells.
  52. TGF-β induce a decrease of NKp30 and not affect the expression of NKp46 and NKG2D.
  53. MSCs have demonstrated their potentiality for treating diseases or repairing damaged tissues
  54. Human adipose-derived stem cells (hASCs) have been successfully used in treating numerous diseases.
  55. Analysis of NK cell-activating receptors and their ligands
  56. The receptor-ligand crosslinking downregulates DNAM-1 expression on NK cells
  57. NK cells are a key component of innate immunity in the regulation of the immune response
  58. The majority of melanoma cell lines express ligands for NKG2D
  59. Prostasomes are small vesicles secreted by the prostate gland to the seminal fluid.
  60. The expression of ligands for NK cell activating receptors is variable on different melanoma cells
  61. Adhesion molecules and ligands involved in cell-mediated cytotoxicity in a melanoma cell lines
  62. Effect of ageing on the phenotype and frequency of CMV pp65-specific CD8 T cell subsets
  63. Transfer of antigen-specific CD8+ T cells may represent an strategy for immunotherapy of tumors
  64. Recombinant lentivectors direct the intracellular synthesis of NY-ESO-1
  65. Functional relevance of HNK-1 expression in metastatic melanoma.
  66. Remodelling of the CD8 T-Cell Compartment in the Elderly
  67. Lymphocyte activation in response to melanoma.
  68. CD8+ T cells can express NK-associated receptors that may regulate their cytolytic function.
  69. Natural killer cell–associated receptor
  70. HIV-1 infected patients show a gradual loss of NK cells that correlates with disease progression
  71. Vα24+ NKT cells are decreased in elderly humans
  72. NK receptors on CD8 T Lymplhocytes in HIV infected individuals
  73. Analysis of expression of CD28 co-stimulatory molecules andNK-Rs
  74. NK Cells in Human Ageing